Washington
Prescription drug spending and prescribing in Washington, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $4.8B for prescriptions written in Washington, the 22nd most of 52 states and territories, and 4.3% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $4.8B
- Medicaid drugs, 2025: $1.8B
- Opioid share of claims: 4.3%
- Life-science raises, 2 years: $559M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Washington | United States | Difference |
|---|---|---|---|
| Opioids | 4.3% | 3.5% | +20% |
| Antibiotics | 3.8% | 4.4% | -15% |
| Antipsychotics | 2.1% | 1.7% | +20% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Washington's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Ciclesonide | 3.9× | 14,869 |
| Beclomethasone Dipropionate | 2.9× | 11,756 |
| Dabigatran Etexilate Mesylate | 2.6× | 34,951 |
| Hydromorphone Hcl | 2.5× | 35,256 |
| Liothyronine Sodium | 2.5× | 33,193 |
| Fluticasone Furoate | 2.3× | 26,379 |
| Methadone Hcl | 2.1× | 20,872 |
| Oxycodone Hcl | 2.1× | 354,868 |
| Prazosin Hcl | 2.1× | 46,778 |
| Insulin Nph Human Isophane | 2.1× | 21,958 |
Biggest Medicaid Drugs
What Washington's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
38 Form D raises by companies based in Washington in the last two years; the 10 largest. See all raises- Tune Therapeutics, Inc.$182M · Biotech · Jan 24, 2025
- CP Venture IV, LP$126M · Other health care · Dec 19, 2025
- Curevo, Inc.$42M · Pharma · Mar 18, 2025
- Bonum Therapeutics, Inc.$27M · Biotech · Apr 17, 2026
- Solius Labs, Inc.$23M · Other health care · May 14, 2026
- Zocalo Health Inc.$23M · Other health care · Apr 21, 2026
- CytoDyn Inc.$19M · Pharma · May 11, 2026
- Aminex Therapeutics, Inc.$15M · Biotech · Dec 5, 2025
- Circulate Health, Inc.$13M · Biotech · Oct 22, 2025
- Digital Biotechnologies, Inc.$12M · Biotech · Dec 31, 2025
State Attorney General Health-Care Cases
Antitrust cases Washington joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- Alabama et al. v. Endo International, No. 3:19-cv-04157 (N.D. Cal. July 19, 2019)2019 · Settled
- California et al. v. Teikoku Seikayu Co.(Lidoderm), No. 3:18-cv-00675 (N.D. Cal. 01/31/18)2018 · Settled
- State of Washington v.Franciscan Health System et al, No. 3:17-cv-05690 (W.D. Wash.Aug. 31, 2017)2017 · Setttled
- FTC and Plaintiff States v. Mallilnckrodt Ard Inc. (formerly Questcor), No. 1:17-cv-00120 (D.D.C. Jan. 18, 2017)2017 · Settled
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- Connecticut et al. v. Teva Pharmaceuticals et al. Civ. Action No. (D.Conn. Dec. 15, 2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Florida et al. v. Abbott Laboratories et al., No. 1:08-cv-00155-SLR (D.Del. 2007)2007 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG